ARDX
Ardelyx, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website ardelyx.com
- Employees(FY) 133
- ISIN US0396971071
Performance
-3.1%
1W
+16.39%
1M
-13.61%
3M
+93.8%
6M
+25.97%
YTD
+98.73%
1Y
Profile
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor for the treatment of patients with irritable bowel syndrome with constipation. It also develops XPHOZAH, which is in Phase III clinical trial to control serum phosphorus in adult patients with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia; RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease; and RDX020, for adult patients with metabolic acidosis, a serious electrolyte disorder. The company has agreements with Kyowa Kirin, Fosun Pharmaceutical Industrial Development Co. Ltd., and Knight Therapeutics, Inc. for the development and commercialization of tenapanor in their respective territories. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Investment Analysis Report: ARDX
Overview
ARDX is a pharmaceutical company operating in the Health Technology sector, specifically in the Pharmaceuticals: Major industry. The company has a market capitalization of $2.1 billion. In this report, we will conduct a comprehensive analysis of ARDX's financial health, earnings and revenue growth, profi...
Technical Analysis of ARDX 2024-05-10
Overview:
In analyzing the technical indicators for ARDX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and recommendations for potential...
Recent News & Updates
- 2024-05-16 08:01
- 2024-05-15 20:01
- 2024-05-15 04:30
7 Cheap Penny Stocks to Buy Now: May 2024(Investorplace)
- 2024-05-14 16:02
Ardelyx, Inc. Reports Employment Inducement Grants(GlobeNewswire)
- 2024-05-14 04:02
Ardelyx, Inc. Reports Employment Inducement Grants(Globenewswire)
- 2024-05-09 16:43
- 2024-05-09 16:42
- 2024-05-07 17:00
- 2024-05-07 08:01
- 2024-05-06 20:01
- 2024-05-04 11:00
Ardelyx, Inc. (NASDAQ:ARDX) Q1 2024 Earnings Call Transcript(Insider Monkey)
- 2024-05-04 08:44
Ardelyx First Quarter 2024 Earnings: Beats Expectations(Simply Wall St.)
- 2024-05-03 23:00
Ardelyx, Inc. (NASDAQ:ARDX) Q1 2024 Earnings Call Transcript(Insidermonkey)
- 2024-05-03 14:16
Ardelyx Shares Rise After Q1 Beat(MT Newswires)
- 2024-05-03 09:57
- 2024-05-03 06:21
Q1 2024 Ardelyx Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-05-02 19:31
- 2024-05-02 17:45
- 2024-05-02 16:47
Ardelyx: Q1 Earnings Snapshot(Associated Press Finance)
- 2024-05-02 16:02
- 2024-05-02 08:58
- 2024-05-02 05:45
- 2024-05-02 04:02
- 2024-05-01 08:00
- 2024-04-30 20:00
- 2024-04-30 10:01
- 2024-04-25 10:02
- 2024-04-24 22:02
- 2024-04-23 14:38
- 2024-04-18 08:00
Page 1 of 7
previousnext